HC-7366 Clinical Trials
3 recruitingDrug
Phase 13
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Kidney CancerPhase 1bHC-7366+1 more
M.D. Anderson Cancer Center35 enrolled1 locationNCT07401875
Recruiting
Phase 1
Phase I Study of HC-7366 for Acute Myeloid Leukemia
Acute Myeloid Leukemia
M.D. Anderson Cancer Center18 enrolled1 locationNCT06285890
Recruiting
Phase 1
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Renal Cell Carcinoma
HiberCell, Inc.80 enrolled20 locationsNCT06234605